Integer Holdings Corporation (ITGR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 03 2026 to Jun 27 2025 - CSIMarket
CSIMarket
 


Integer Holdings Corporation  (NYSE: ITGR)


Integer Holdings's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Integer Holdings's ROI in the second quarter of 2026?
Integer Holdings Corporation achieved a return on average invested assets (ROI) of 4.02 % in its second quarter of 2026, this is above ITGR's average return on investment of 3.3%.
Integer Holdings Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $3 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 43.01% from the first quarter of 2026.

Within the Healthcare sector 148 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1289 to 1673.

Definition and Formula of Return on Investment



Return On Investment (Jul 03 2026)
II. Quarter
(Apr 03 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 26 2025)
III. Quarter
(Jun 27 2025)
II. Quarter
Y / Y Investment Change TTM 6.11 % 7.78 % 8.44 % 4.91 % 5.63 %
Y / Y Net Income Change TTM 55.32 % 84.39 % 3.44 % 30.32 % 164.56 %
Investment (TTM) in Millions 3,206 3,205 3,179 3,187 3,155
Return On Investment (TTM) 4.02 % 4.46 % 3.26 % 2.83 % 2.75 %
ITGR's Overall Ranking # 1673 # 1289 # 1269 # 1624 # 1484
Seq. Investment Change TTM 0.41 % 0.9 % 2.67 % 2.01 % 1.99 %
Seq. Net Income Change TTM -9.45 % 37.93 % 18.3 % 5.13 % 7.49 %
Net Income (TTM) in Millions 128 142 103 87 83




Return On Investment ITGR's Ranking
Within: No.
Industry # 49
Sector # 149
Overall # 1673

Return On Investment Statistics
High Average Low
8.62 %
3.3 %
-1.7 %
(Jun 28 2019)   (Jul 01 2016)







Financial Statements
Integer Holdings's II. Quarter Investments $ 3,206 Millions ITGR's Balance sheet
Integer Holdings's II. Quarter Income $ 24 Millions Quarterly ITGR's Income Statement
ITGR's Income by Division See ITGR's Income by Division


ITGR Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 3,179 2,851 2,722 2,571 2,423
Y / Y Investment Growth 11.5 % 4.74 % 5.88 % 6.11 % 9.34 %
Net Income in Millions 103 120 91 66 97
Y / Y Net Income Growth -14.25 % 32.26 % 36.57 % -31.43 % 25.3 %
Annual Return On Investment 3.23 % 4.21 % 3.33 % 2.58 % 4 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 3.23 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ITGR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ITGR's Competitors
Subscribers only: Roi for Integer Holdings's Suppliers
Subscribers only: Return On Investment for ITGR's Customers

Other Ratios
ITGR's Roa ITGR's Inventory Turnover Ratio ITGR's Growth Rates ITGR's Dividend Statistics
ITGR's Profitability Ratios ITGR's Asset Turnover Ratio ITGR's Dividend Growth
ITGR's Roe ITGR's Valuation Ratios ITGR's Financial Strength Ratios ITGR's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 03 2026, within Healthcare Sector ROI
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %
Veracyte Inc   8.15 %
Phibro Animal Health Corporation  8.11 %
Brightspring Health Services Inc   8.05 %
Quest Diagnostics Inc  8.05 %
Addus Homecare Corp  7.98 %
Corcept Therapeutics Inc  7.96 %
Amneal Pharmaceuticals Inc   7.91 %
Concentra Group Holdings Parent Inc   7.89 %


Date modified: 2026-09-12T06:15:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.